Inventor · disambiguated record
David Menaldino
Also filed as: MENALDINO DAVID · MENALDINO DAVID S · MENALDINO DAVID STEVEN
4 granted patents·5 pending applications·4 citations·filing 2005–2024
64Inventor score
Top patents by PatentIndex Score
9 records- 0179US12415790B2GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pHUNIV EMORY·Filed 2024·Granted Sep 16, 2025·0 cites·20 claims
- 0275US11738008B2N-methyl-D-aspartic acid receptor modulatorsUNIV EMORY·Filed 2019·Granted Aug 29, 2023·1 cites·9 claims
- 0374US10647679B2N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and uses related theretoUNIV EMORY·Filed 2016·Granted May 12, 2020·2 cites·12 claims
- 0467US7632828B2Gram-positive carbapenem antibacterials and processes for their preparationFOB SYNTHESIS INC·Filed 2005·Granted Dec 15, 2009·1 cites·85 claims
- 0565US2024360091A1Glun2b-subunit selective antagonists of the n-methyl-d-aspartate receptors with enhanced potency at acidic phUNIV EMORY·Filed 2022·Application pending·0 cites
- 0659US2010075945A1Gram-positive carbapenem antibacterials and processes for their preparationCHOI WOO-BAEG·Filed 2009·Application pending·0 cites
- 0757US2024217979A1GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate ReceptorsUNIV EMORY·Filed 2022·Application pending·0 cites
- 0847US2023339854A1Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate ReceptorsUNIV EMORY·Filed 2021·Application pending·0 cites
- 0942US2014275060A1Compounds for the treatment of neurologic disordersMENALDINO DAVID STEVEN·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →